A Randomized Trial of Radical Cystectomy Versus Radical Cystectomy Plus Cisplatin, Vinblastine and Methotrexate Chemotherapy for Muscle Invasive Bladder Cancer-Reference-Cited by-同舟云学术

A Randomized Trial of Radical Cystectomy Versus Radical Cystectomy Plus Cisplatin, Vinblastine and Methotrexate Chemotherapy for Muscle Invasive Bladder Cancer

Published:1996-02 Issue:2 Volume:155 Page:495-500
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Freiha Fuad¹,Reese Jeffrey¹,Torti Frank M.¹

Affiliation:

1. Departments of Urology and Medicine, Stanford University School of Medicine Stanford and Department of Veterans Affairs, Palo Alto, California.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Stage B (P2/3A/No) transitional cell carcinoma of bladder highly curable by radical cystectomy;Wishnow;Urology,1992

2. Radikale Zystecktomie - oft zu spat? Akt;Stockle;Urol.,1986

3. The rationale for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results;Lerner;J. Urol.,1993

4. The upper limits of hopeful application of radical cystectomy for vesical carcinoma: does nodal metastasis always indicate incurability?;LaPlante;J. Urol.,1973

5. The value of pelvic lymphadenectomy in the surgical treatment of bladder cancer;Dretler;J. Urol.,1973

Cited by 302 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative chemotherapy and immunotherapy to optimize cystectomy outcomes in the curative intent of non-metastatic muscle-invasive bladder cancer: A systematic review and meta-analysis;The French Journal of Urology;2024-09

2. A narrative review of management of muscle-invasive bladder cancer perioperative period: will continuous and combined treatment be the new trend?;Translational Andrology and Urology;2024-02

3. Cell-free DNA Methylation as a Predictive Biomarker of Response to Neoadjuvant Chemotherapy for Patients with Muscle-invasive Bladder Cancer in SWOG S1314;European Urology Oncology;2023-10

4. Adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible high-risk bladder cancer patients: Long-term follow-up of a randomized phase 3 trial;Urologic Oncology: Seminars and Original Investigations;2023-08

5. Survival Benefits of Adjuvant Chemotherapy for Positive Soft Tissue Surgical Margins Following Radical Cystectomy in Bladder Cancer with Extravesical Extension;Current Oncology;2023-03-10